TBTC Study 23C: Pharmacokinetics of Intermittent Rifabutin and Isoniazid With Daily Efavirenz

NCT00023413 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

FED

Sponsor class

Conditions

HIV Infections
Tuberculosis

Interventions

DRUG: Rifabutin
DRUG: Efavirenz

Sponsor

Centers for Disease Control and Prevention

Collaborators

[object Object]